Astellas Pharma Inc. YPH.F · Stock Open Astellas Pharma Inc. in new tab
Astellas Pharma Inc. Analysis (YPH.F)
Is Astellas Pharma Inc. a good investment? Astellas Pharma Inc. (YPH.F) is currently trading at 12.80 EUR.
In terms of valuation, the stock trades at a P/E ratio of 14.07. This relatively low multiple may signal that Astellas Pharma Inc. is undervalued compared to historical market norms.
For income investors, Astellas Pharma Inc. pays a dividend yield of 3.28%. With a payout ratio of 48%, the dividend appears sustainable.
Investor FAQ
Does Astellas Pharma Inc. pay a dividend?
Yes, it pays an annual dividend of 0.43 EUR (3.28% yield).
What asset class is Astellas Pharma Inc.?
Astellas Pharma Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.
Company Profile
Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It also provides VEOZAH, a treatment for vasomotor symptoms associated with menopause; IZERVAY, a treatment for age-related macular degeneration with geographic atrophy; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf, an immunosuppressant. It offers its products to oncology, ophthalmology, urology, immunology, and women's health areas. The company was formerly known as Yamanouchi Pharmaceutical Co. Ltd. and changed its name to Astellas Pharma Inc. in April 2005. Astellas Pharma Inc. was founded in 1923 and is headquartered in Chuo, Japan.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.25 EUR
|
| March 29, 2027 (estimated) | 0.2490 |
| ▸2026 |
0.22 EUR
|
| March 30, 2026 | 0.2162 |
| ▸2025 |
0.42 EUR
|
| Sept. 29, 2025 | 0.2162 |
| March 28, 2025 | 0.2051 |
| ▸2024 |
0.40 EUR
|
| Sept. 27, 2024 | 0.2051 |
| March 28, 2024 | 0.1941 |
| ▸2023 |
0.36 EUR
|
| Sept. 28, 2023 | 0.1941 |
| March 30, 2023 | 0.1663 |
| ▸2022 |
0.30 EUR
|
| Sept. 29, 2022 | 0.1663 |
| March 30, 2022 | 0.1386 |
| ▸2021 |
0.26 EUR
|
| Sept. 29, 2021 | 0.1386 |
| March 30, 2021 | 0.1164 |
| ▸2020 |
0.23 EUR
|
| Sept. 29, 2020 | 0.1164 |
| March 30, 2020 | 0.1109 |
| ▸2019 |
0.22 EUR
|
| Sept. 27, 2019 | 0.1109 |
| March 27, 2019 | 0.1053 |
| ▸2018 |
0.21 EUR
|
| Sept. 26, 2018 | 0.1053 |
| March 28, 2018 | 0.0998 |
| ▸2017 |
0.19 EUR
|
| Sept. 27, 2017 | 0.0998 |
| March 29, 2017 | 0.0943 |
| ▸2016 |
0.18 EUR
|
| Sept. 28, 2016 | 0.0943 |
| March 29, 2016 | 0.0887 |
| ▸2015 |
0.18 EUR
|
| Sept. 28, 2015 | 0.0887 |
| March 27, 2015 | 0.0887 |
| ▸2014 |
0.16 EUR
|
| Sept. 26, 2014 | 0.0776 |
| March 27, 2014 | 0.0776 |
| ▸2013 |
0.14 EUR
|
| Sept. 26, 2013 | 0.0721 |
| March 27, 2013 | 0.0721 |
| ▸2012 |
0.14 EUR
|
| Sept. 26, 2012 | 0.0721 |
| March 28, 2012 | 0.0721 |
| ▸2011 |
0.14 EUR
|
| Sept. 28, 2011 | 0.0665 |
| March 29, 2011 | 0.0721 |
| ▸2010 |
0.14 EUR
|
| Sept. 28, 2010 | 0.0665 |
| March 29, 2010 | 0.0721 |
| ▸2009 |
0.13 EUR
|
| Sept. 25, 2009 | 0.0665 |
| March 26, 2009 | 0.0665 |
| ▸2008 |
0.13 EUR
|
| Sept. 25, 2008 | 0.0665 |
| March 26, 2008 | 0.0665 |
| ▸2007 |
0.10 EUR
|
| Sept. 25, 2007 | 0.0554 |
| March 27, 2007 | 0.0444 |
| ▸2006 |
0.09 EUR
|
| Sept. 26, 2006 | 0.0444 |
| March 28, 2006 | 0.0444 |
| ▸2005 |
0.05 EUR
|
| Oct. 3, 2005 | 0.0333 |
| April 1, 2005 | 0.0177 |
| ▸2004 |
0.03 EUR
|
| Oct. 1, 2004 | 0.0166 |
| April 1, 2004 | 0.0177 |
| ▸2003 |
0.02 EUR
|
| Sept. 25, 2003 | 0.0166 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Astellas Pharma Inc. | Mar 30, 2026 | Paid | 0.216228 EUR |
Community Discussion